Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Edinburgh vets treat cat with rare cancer
Misha in recovery.

Misha the cat is now in remission from plasma cell cancer. 

Misha the 14-year-old shorthair cat is in remission from plasma cell cancer after care from several teams at the Royal (Dick) School of Veterinary Studies.

The cancer was discovered when preparation for dental work revealed that there was a change in Misha's liver health, and from there, it was discovered that he had cancer affecting several of his organs.

After further testing, it was discovered that Misha had multicentric plasma cell neoplasia, which had caused tumours in his spleen, liver and on a lymph node. 

Collaborating on Misha's treatment, teams from feline medicine, surgery, intensive care, pathology, oncology, and dentistry were able to remove the cat's spleen and the tumours on his lymph node, and used chemotherapy to treat the tumours on his liver. 

Four months post-treatment, scans of Misha have suggested his condition to be significantly better. He has no visible lesions on his organs, and his enzyme levels have improved. Still recovering at home, Misha is receiving ongoing low-dose chemotherapy. 

Misha's owner, and radiologist at the Dick Vet, Tobias Schwarz, commented: “I’m very happy that Misha is now doing so well. His illness highlights the importance of regular health checks to help spot issues that may otherwise be undiagnosed, and the benefit of treating animals early on their illness, to improve their chances of recovery.

“With advances in oncology, successful treatment of cancer in animals is becoming more common, and consequently other important diseases, such as dental disorders, need to be considered for treatment as well, if we want to improve the health and welfare of our animals.”

 

Image (C) The Royal (Dick) School of Veterinary Studies

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
NSA webinar explores sheep tailing and castration

The National Sheep Association (NSA) is to host a free webinar on the castration and tail docking of lambs.

The webinar, 'Understanding the tailing and castration consultation: A guide for sheep farmers', will be hosted online on Monday, 2 March 2026 at 7.30pm.

It comes during a government consultation into the methods used for these procedures. Farmers are encouraged to engage before the consultation period closes on Monday, 9 March 2026.

The webinar offers clear and actionable guidance to support farmers to contribute meaningfully to the consultation and prepare for potential changes.

On the panel will be former SVS president Kate Hovers, farmer and vet Ann Van Eetvelt and SRUC professor in Animal Health and Veterinary Sciences Cathy Dwyer. Each panel member will utilise their own specialism and expertise to evaluate risks and outcomes to sheep farming.

Find out more about the webinar on the NSA website.